Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | XBP1 | P17861 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.50 |
| ▸ | GPR3 | P46089 | 1/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.47 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28126443 | 0.98 | LMNA (0.49) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Water SCHEMBL27843768 | 0.98 | LMNA (0.49) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Formaldehyde SCHEMBL28103446 | 0.93 | MAPT (0.50) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Phenol SCHEMBL28313835 | 0.89 | LMNA (0.47) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Anisole SCHEMBL27928792 | 0.89 | CA4 (0.56) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Acetonitrile SCHEMBL27860688 | 0.88 | MAPT (0.46) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| SCHEMBL2494091 | 0.88 | MAPT (0.46) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| SCHEMBL498377 | 0.87 | ALDH1A1 (0.56) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| SCHEMBL7467325 | 0.87 | PIK3CD (0.54) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| Acetaldehyde SCHEMBL27974244 | 0.86 | MEN1 (0.45) | ALDH1A1LMNAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197345-A1 | SYNTHESIS OF DIGLYCOLAMIDES | UNITED STATES DEPARTMENT OF ENERGY | 2025-06-19 | — | — | US | claimed |
| EP-4370733-A2 | METHODS AND DEVICES FOR ENRICHING A SUBSTRATE WITH AN ALKALI METAL, AND ELECTROLYTE | RENA Technologies GmbH (DE) | 2024-05-22 | — | — | EP | claimed |
| CN-116864809-A | Lithium ion battery electrolyte and application thereof | 远景动力技术(江苏)有限公司 | 2023-10-10 | — | — | CN | claimed |
| WO-2023284918-A2 | METHODS AND DEVICES FOR ENRICHING A SUBSTRATE WITH AN ALKALI METAL, AND ELECTROLYTE | RENA Technologies GmbH (DE) | 2023-01-19 | — | — | WO | claimed |
| CN-111816935-A | Method of charging secondary lithium metal batteries to reactivate dead lithium with redox shuttle additives and battery control system incorporating the method | 麻省固能控股有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-7763602-B2 | Pyrrole derivatives as antimycobacterial compounds | LUPIN LIMITED (IN) | 2010-07-27 | — | — | US | claimed |
| US-7691837-B2 | Pyrrole derivatives as antimycobacterial compounds | LUPIN LIMITED (IN) | 2010-04-06 | — | — | US | claimed |
| EP-2079674-A1 | PROCESS FOR THE PREPARATION OF TRIFLUOROETHOXYTOLUENES | Grindeks, a joint stock company (LV) | 2009-07-22 | — | — | EP | claimed |
| WO-2008055849-A1 | PROCESS FOR THE PREPARATION OF TRIFLUOROETHOXYTOLUENES | GRINDEKS, A JOINT STOCK COMPANY (LV) | 2008-05-15 | — | — | WO | claimed |
| US-20040220409-A1 | Flecainide synthesis | MCDANIEL WILLIAM C | 2004-11-04 | — | — | US | claimed |
| WO-2002066413-A1 | FLECAINIDE SYNTHESIS | NARCHEM CORPORATION (US) | 2002-08-29 | — | — | WO | claimed |
| US-4643811-A | PHOTOCHLORINATION | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1987-02-17 | — | — | US | claimed |
| US-12527779-B2 | Prostaglandin E2 (PGE2) EP4 receptor antagonists | DOMAIN THERAPEUTICS (FR) | 2026-01-20 | — | — | US | disclosed |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | BAYER AKTIENGESELLSCHAFT (DE) | 2025-07-15 | — | — | US | disclosed |
| US-12336981-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| US-20250197345-A1 | SYNTHESIS OF DIGLYCOLAMIDES | UNITED STATES DEPARTMENT OF ENERGY | 2025-06-19 | — | — | US | disclosed |
| EP-0023422-B1 | HERBICIDAL SULFONAMIDES, PREPARATION AND USE THEREOF, AND COMPOSITIONS CONTAINING THEM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-02-22 | — | — | EP | disclosed |
| EP-0064322-A2 | Benzenesulfonyl isocyanates, isothiocyanates, chlorides, and sulfonamides having a fluorinated substituent | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-11-10 | — | — | EP | disclosed |
| EP-0057546-A2 | Sulfonylurea N-oxides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-08-11 | — | — | EP | disclosed |
| EP-0023422-A2 | Herbicidal sulfonamides, preparation and use thereof, and compositions containing them | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527779-B2 | Prostaglandin E2 (PGE2) EP4 receptor antagonists | PTGER1, PTGER4, PTGER3 | ALDH1A1 687/4885LMNA 1849/4885MAPT 4848/4885 |
| US-20040220409-A1 | Flecainide synthesis | KCNH1, CYP3A43, CYP2F1 | ALDH1A1 450/4885LMNA 2760/4885MAPT 4170/4885 |
| US-12336981-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNMT, NNT | ALDH1A1 984/4885LMNA 860/4885MAPT 256/4885 |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | KAT6A, KAT6B, KAT2A | ALDH1A1 1645/4885LMNA 3460/4885MAPT 4715/4885 |
| US-20250197345-A1 | SYNTHESIS OF DIGLYCOLAMIDES | RPN2, FUT6, RPN1 | ALDH1A1 2645/4885LMNA 1820/4885MAPT 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.